SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-16-000162
Filing Date
2016-03-15
Accepted
2016-03-15 16:05:17
Documents
3
Period of Report
2016-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT opxa_8k.htm 8-K 45798
2 PRESS RELEASE opxa_ex991.htm EX-99.1 77259
3 IMAGE logo.jpg GRAPHIC 4460
  Complete submission text file 0001654954-16-000162.txt   130811
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 161506935
SIC: 2834 Pharmaceutical Preparations